|
Time 1 Baseline (1990-1993) |
Time 3 First Follow-up (1995-1996) |
Second Follow-up (1997-1998) |
Third Follow-up (2000) |
Fourth Follow-up (2004-05) |
|||||||||||
|
Actual age group
|
N=258 |
N=258 |
N=516 |
N=101 |
N=105 |
N=206 |
N=60 |
N=72 |
N=132 |
N=32 |
N=50 |
N=182 |
N=16 |
N=30 |
N=46 |
|
70-74 |
43 (16.7%) |
43 (16.7%) |
86 (16.7%) |
5 (5.0%) |
8 (7.6%) |
13 (6.3%) |
2 (3.3%) |
1 (1.4%) |
3 (2.3%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
|
75-79 |
43 (16.7%) |
43 (16.7%) |
86 (16.7%) |
37 (36.6%) |
28 (26.7%) |
65 (31.6%) |
19 (31.7%) |
19 (26.4%) |
38 (28.8%) |
1 (3.1%) |
4 (8.0%) |
5 (6.1%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
|
80-84 |
43 (16.7%) |
43 (16.7%) |
86 (16.7%) |
24 (23.8%) |
28 (26.7%) |
52 (25.2%) |
17 (28.3%) |
26 (36.1%) |
43 (32.6%) |
19 (58.4%) |
16 (32.0%) |
35 (42.7%) |
2 (12.5%) |
4 (13.3%) |
6 (13.0%) |
|
85-89 |
43 (16.7%) |
43 (16.7%) |
86 (16.7%) |
16 (15.8%) |
24 (22.9%) |
40 (19.4%) |
14 (23.3%) |
15 (20.8%) |
29 (22.0%) |
6 (18.8%) |
20 4(0.0%) |
26 (31.7%) |
10 (62.5%) |
13 (43.3%) |
23 (50.0%) |
|
90-94 |
43 (16.7%) |
43 (16.7%) |
86 (16.7%) |
9 (8.9%) |
7 (6.7%) |
16 (7.8%) |
6 (10.0%) |
7 (9.7%) |
13 (9.8%) |
5 (15.6%) |
9 (18.0%) |
14 (17.1%) |
2 (12.5%) |
10 (33.3%) |
12 (26.1%) |
|
95+ |
43 (16.7%) |
43 (16.7%) |
86 (16.7%) |
10 (9.9%) |
10 (9.5%) |
20 (9.7%) |
2 (3.3%) |
4 (5.6%) |
6 (4.5%) |
1 (3.1%) |
1 (2.0%) |
2 (2.4%) |
2 (12.5%) |
3 (10.0%) |
5 (10.9%) |